PD-L1 Rabbit Monoclonal Antibody

PD-L1 Rabbit Monoclonal Antibody

Size1:50μL Price1:$188
Size2:100μL Price2:$338
Application:WB, IHC-P, ICC/IF, FC, IP

Reactivity:Human
Conjugate:Unconjugated
Optional conjugates: Biotin, FITC (free of charge).
See other 26 conjugates.

Gene Name:PD-L1
SKU: AMRe86409 Category: Recombinant Monoclonal Antibody Tags: , , , , , , ,

Summary

Production Name

PD-L1 Rabbit Monoclonal Antibody

Description

Rabbit Monoclonal antibody

Host

Rabbit

Application

WB, IHC-P, ICC/IF, FC, IP

Reactivity

Human

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

IgG

Clonality

Monoclonal Antibody

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% protective protein . Stable for 12 months from date of receipt.

Purification

Affinity Purification

 

Immunogen

Gene Name

PD-L1

Alternative Names

B7-H; B7H1; PDL1; PD-L1; PDCD1L1; PDCD1LG1

Gene ID

29126

SwissProt ID

Q9NZQ7

 

Application

Dilution Ratio

WB: 1:1000 IHC-P: 1:100-1:200 ICC/IF: 1:200-1:500 FC: 1:200-1:500 IP: 1:20-1:50

Molecular Weight

Calculated MW:33 kDa; Observed MW:40-50 kDa

 

Background

This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]

 

Research Area

Cell adhesion molecules (CAMs);